Carla J. de Boer - Concepedia

Author

Carla J. de Boer

Also Known As

B Zhong, C Boer, C J De Boer, C J de Boer, C. Boer, C. J. de Boer, C.J. Boer, C.J. de Boer, Carla J de Boer, Carla J. de Boer

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Janssen (Netherlands)Leiden University Janssen (United States)Janssen (Belgium)UCSF Helen Diller Family Comprehensive Cancer Center

About

Carla J. de Boer is an author at Janssen (Netherlands) specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	785
2	Pathology	5	5	315
3	Cell Biology	4	4	320
4	Immunology	2	2	325
5	Obstetrics	1	1	87

Carla J. de Boer

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, New England Journal of Medicine	2023	435
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver Carla J. de Boer, J. Han van Krieken, Connie M. Janssen‐van Rhijn, The Journal of Pathology	1999	235
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study Irene Braña, Antonio Calles, Patricia LoRusso, Targeted Oncology Solid TumorsMedicineImmunologyImmune Checkpoint InhibitorCancer Treatment	2014	208
Mantle-cell lymphoma: a population-based clinical study. Gerjo A. Velders, Hanneke C. Kluin‐Nelemans, Carla J. de Boer, Journal of Clinical Oncology	1996	188
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Carla J. de Boer, J. Han van Krieken, Hanneke C. Kluin‐Nelemans, PubMed	1995	125
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort Matthew R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan, European Urology	2016	123
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Carla J. de Boer, S. A. J. Loyson, P.M. Kluin, PubMed Bcl-1 RearrangementsMixed-phenotype Acute LeukemiaImmunologyPathologyTumor Biology	1993	117
Liposomal Amphotericin B (AmBisome) in the Treatment of Complicated Kala-Azar Under Field Conditions Jill Seaman, Carla J. de Boer, Robert J. Wilkinson, Clinical Infectious Diseases	1995	112
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma Bastian von Tresckow, Franck Morschhauser, Vincent Ribrag, Clinical Cancer Research	2015	111
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide Dana E. Rathkopf, Matthew R. Smith, Charles J. Ryan, Annals of Oncology UrologyOncologyMedicineAndrogen Receptor MutationsCastration-resistant Prostate Cancer	2017	98

Page 1